PURE Bioscience Year End Results  Today's Calls

· PrecisionIR · VcallConferences · Annual Reports Service Download Plug-In Real Player 8 Basic Windows Media Player Other Conference Calls Other Oct 14 Calls Today's Calls

Call Details PURE Bioscience Year End Results Wed, Oct 14, 2009, 4:30 pm Eastern Listen to the archived event audio About PURE Bioscience (NasdaqCM:PURE) PURE Bioscience engages in the development and commercialization of silver ion bioscience technologies principally in the United States. The company offers silver dihydrogen citrate-based antimicrobials. The silver dihydrogen citrate technology is an electrolytically generated source of stabilized ionic silver that would serve as the basis for various products in diverse markets. It also provides Axen and Axen30 hard surface disinfectant products for commercial, industrial, and consumer applications, including restaurants, homes, and medical facilities. PURE Bioscience sells its products to retail, commercial, and institutional customers through distributors. The company was founded in 1992 and is headquartered in El Cajon, California. More Info: Quote | Profile | Reports | Research | SEC | Insider | Analyst Ratings